XIONG Yan, ZHANGT Tao. Exploring Professor Xiong Yan. 2025. biomedRxiv.202509.00053
Exploring Professor Xiong Yan
Corresponding author: ZHANGT Tao, hello_zhangtao@aliyun.com
DOI: 10.12201/bmr.202509.00053
- 
							 
								 
									
Abstract: Non-alcoholic fatty liver disease (NAFLD) has a complex pathogenesis. In traditional Chinese medicine (TCM), its occurrence is closely associated with dietary habits, emotional factors, and constitutional predisposition. Based on the “Xiao Fa” (dispersion method) theory, this article systematically summarizes Professor Xiong Yan’s clinical experience in treating NAFLD, highlighting innovations in pathological mechanism interpretation and stratified treatment.Professor Xiong identifies three key pathological mechanisms: dietary irregularities leading to spleen-stomach impairment, emotional disorders causing liver stagnation overacting on the spleen, and congenital deficiency resulting in phlegm and stasis binding together. These factors interact, ultimately leading to liver-spleen dysfunction and phlegm-stasis obstruction.Therapeutically, centering on “Xiao Fa,” a stratified treatment approach is adopted: promoting digestion and removing stagnation, awakening the spleen and resolving turbidity to strengthen the middle energizer; soothing the liver and relieving depression, eliminating stagnation and harmonizing collaterals to regulate qi movement; resolving phlegm and dissipating stasis, supporting healthy qi and unblocking collaterals to eliminate pathogens and consolidate constitution. Professor Xiong also developed the empirical formula “Zhi Kang Yin” to simultaneously address the liver and spleen, and treat both phlegm and stasis, reflecting the uniqueness and practicality of his clinical approach. This provides a new effective formula and clinical pathway for TCM treatment of NAFLD.
Key words: Non-alcoholic fatty liver disease,Therapy of Dispelling,Zhi Kang Yin,ExperienceSubmit time: 24 September 2025
Copyright: The copyright holder for this preprint is the author/funder, who has granted biomedRxiv a license to display the preprint in perpetuity. - 
								
图表
 - 
								
王馨雨, ZHANG Shujuan. Research progress of GLP-2 in non-alcoholic fatty liver disease. 2025. doi: 10.12201/bmr.202502.00018
Chen Zhiyun. Effects of common environmental pollutants on non-alcoholic fatty liver disease. 2025. doi: 10.12201/bmr.202506.00049
NIU Xiao Shan. Advances in pharmacological studies of NF-κB involved in the regulation of nonalcoholic fatty liver disease. 2024. doi: 10.12201/bmr.202410.00006
Li Xue, Fei Yue, Xu Xiahong. Exploring the relationship between serum ferritin and metabolic-associated fatty liver disease in adolescents based on NHANES database. 2025. doi: 10.12201/bmr.202503.00012
JIA Chen, GONG Yan, HAN Yijing, JIANG Jianan, LIU Weizheng, ZHANG Daxu, LU Wenping. Correlation between psychological stress and metabolic-associated fatty liver disease. 2022. doi: 10.12201/bmr.202204.00003
. 2025. doi: 10.12201/bmr.202507.00044
Xiaozhihong. . 2025. doi: 10.12201/bmr.202509.00057
Song Si-Meng, Wang Shi-Liang, Wu da-hua, XIE Le. Professor Zhou Shens experience in treating delayed motor disorder based on the theory of. 2025. doi: 10.12201/bmr.202509.00038
刘永淳, Luo Liangtao, Gao Zhongying. Professor Gao Zhongyings experience in treating chronic atrophic gastritis from the theory of. 2024. doi: 10.12201/bmr.202410.00062
Tian Lin. Professor Tian Lins Experience Sharing and Case Studies in the Treatment of Lung Adenocarcinoma. 2025. doi: 10.12201/bmr.202506.00019
 - 
								
ID Submit time Number Download 1 2025-09-12 10.12201/bmr.202509.00053V1
Download  - 
								
 - 
								Public Anonymous To author only
 
Get Citation
Article Metrics
- Read: 316
 - Download: 0
 - Comment: 0
 

Login
Register
	                



京公网安备